← All trials
NCT05752201
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 6, 2023
- Primary completion
- Aug 22, 2023
- Completion date
- Dec 7, 2023
- First posted
- Mar 2, 2023
- Last posted
- Dec 22, 2023
- Enrollment
- 2014
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoLead sponsor
- Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoOverall official - principal investigator
- Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoReponsible party - principal investigator
- National Council of Scientific and Technical Research, ArgentinaCollaborator
- Universidad Nacional de San Martín (UNSAM)Collaborator
- Laboratorio Pablo Cassará S.R.L.Collaborator
- Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoSponsor investigator
- Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.